Geode Capital Management LLC Has $3.94 Million Stock Holdings in Nature’s Sunshine Products, Inc. (NASDAQ:NATR)

Geode Capital Management LLC decreased its stake in shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) by 0.7% during the 3rd quarter, Holdings Channel reports. The firm owned 288,976 shares of the company’s stock after selling 1,981 shares during the period. Geode Capital Management LLC’s holdings in Nature’s Sunshine Products were worth $3,937,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in NATR. XTX Topco Ltd bought a new stake in shares of Nature’s Sunshine Products in the 2nd quarter valued at about $180,000. Barclays PLC raised its stake in Nature’s Sunshine Products by 51.8% in the third quarter. Barclays PLC now owns 35,602 shares of the company’s stock valued at $485,000 after buying an additional 12,152 shares during the period. Bank of New York Mellon Corp lifted its position in shares of Nature’s Sunshine Products by 12.6% in the second quarter. Bank of New York Mellon Corp now owns 48,589 shares of the company’s stock valued at $732,000 after buying an additional 5,425 shares during the last quarter. Jacobs Levy Equity Management Inc. boosted its stake in shares of Nature’s Sunshine Products by 7.7% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 67,258 shares of the company’s stock worth $916,000 after acquiring an additional 4,820 shares during the period. Finally, American Century Companies Inc. increased its holdings in shares of Nature’s Sunshine Products by 25.7% during the 2nd quarter. American Century Companies Inc. now owns 260,479 shares of the company’s stock worth $3,925,000 after acquiring an additional 53,221 shares during the last quarter. Institutional investors own 79.40% of the company’s stock.

Insider Activity

In other news, major shareholder Fosun Pharmaceutical Shanghai sold 3,000 shares of Nature’s Sunshine Products stock in a transaction that occurred on Thursday, October 10th. The shares were sold at an average price of $13.39, for a total value of $40,170.00. Following the completion of the sale, the insider now directly owns 69,347 shares in the company, valued at approximately $928,556.33. The trade was a 4.15 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 4.70% of the stock is currently owned by company insiders.

Nature’s Sunshine Products Price Performance

Shares of NASDAQ NATR opened at $14.71 on Tuesday. The firm has a market cap of $271.78 million, a price-to-earnings ratio of 16.72 and a beta of 0.96. The stock’s fifty day moving average price is $15.30 and its two-hundred day moving average price is $14.53. Nature’s Sunshine Products, Inc. has a one year low of $10.81 and a one year high of $21.72.

Analysts Set New Price Targets

A number of equities analysts have commented on NATR shares. Canaccord Genuity Group started coverage on shares of Nature’s Sunshine Products in a research report on Friday, September 13th. They set a “buy” rating and a $18.00 price objective for the company. Canaccord Genuity Group began coverage on shares of Nature’s Sunshine Products in a report on Friday, September 13th. They set a “buy” rating and a $18.00 target price for the company. Finally, StockNews.com upgraded shares of Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, September 10th.

Nature’s Sunshine Products Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.